Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating depression in substance abusers.

Edward V Nunes1, Frances R Levin

  • 1New York State Psychiatric Institute, 1051 Riverside Drive (Unit 51), New York, NY 10032, USA. nunesed@pi.cpmc.columbia.edu

Current Psychiatry Reports
|September 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between naloxone distribution, buprenorphine treatment and retention and incident high-risk opioid prescribing with opioid overdose death in Kentucky, Massachusetts, New York and Ohio, United States: An exploratory community-level cohort study of data from the HEALing Communities Study.

Addiction (Abingdon, England)·2026
Same author

A Comparison of Neuropsychological Functioning Between Patients With Opioid Use Disorder Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone.

Journal of addiction medicine·2026
Same author

Beneficial effects of the rapid vs. standard procedure for injection naltrexone initiation operate through increased adjunctive medication use.

Drug and alcohol dependence·2026
Same author

Decisional incentive sensitivity is linked to contingency management outcome and striatal dopamine signaling in individuals with cocaine use disorder: a preliminary study.

Addiction and substance abuse·2026
Same author

Patient Characteristics Associated with Successful Initiation of Extended-Release Naltrexone in the X:BOT Trial.

Substance use & misuse·2026
Same author

Research Ethics in Stopping Opioid Use Disorder Medication.

JAMA psychiatry·2026
Same journal

Involuntary Celibacy in the Digital Age: a Critical Narrative Review of the Incel Phenomenon, Mental Health Burden, Ideological Pathways, and Public Health Implications.

Current psychiatry reports·2026
Same journal

Is Technology Remaking Therapy: The Screen and the Self: Telepsychiatry, AI Therapy, and the Defense Against Intimacy.

Current psychiatry reports·2026
Same journal

Bridging Gaps in Perinatal Mental Health: A Review of Peer and Non-specialist Supports for Racially, Ethnically and Culturally Diverse Communities in the U.S.

Current psychiatry reports·2026
Same journal

Psychosocial Preparedness for Disasters: A Scoping Review of International Models and Public Health Priorities.

Current psychiatry reports·2026
Same journal

Artificial Intelligence in Child and Adolescent Psychiatry: A Narrative Review of Recent Clinical Applications and Ethical Considerations.

Current psychiatry reports·2026
Same journal

The Digital Mirror: Clinical Potentials and Relational Risks of Generative AI in Mental Health Interventions.

Current psychiatry reports·2026
See all related articles

Effective treatment for co-occurring depression and substance dependence involves addressing substance use first, followed by diagnosing and treating depression. Antidepressant medication shows efficacy with careful diagnosis during abstinence.

Area of Science:

  • Psychiatry
  • Clinical Psychology
  • Addiction Medicine

Background:

  • Co-occurring depression and substance dependence present complex clinical challenges.
  • Existing literature provides a basis for diagnosis and treatment strategies.

Purpose of the Study:

  • To review the literature on diagnosing and treating depression in patients with substance dependence.
  • To provide recommendations for clinical practice, research, and service delivery.

Main Methods:

  • Literature review of diagnostic criteria and treatment efficacy studies.
  • Analysis of placebo-controlled trials for antidepressant medications in substance-dependent patients.

Main Results:

  • Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria offer a reliable diagnostic framework.

Related Experiment Videos

  • Antidepressant medication is effective for depression in substance-dependent patients when diagnosed carefully during abstinence.
  • A phased treatment approach is recommended, prioritizing substance dependence treatment.

    • Conclusions:

    • Integrated care models and further research into psychotherapeutic interventions are needed.
    • Disseminating effective diagnostic and treatment methods can bridge the gap between mental health and substance abuse services.